U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Aging announces the availability of funding for implementation of the Planning Grants for Alzheimer's Disease Translational Centers for Predictive Drug Development (R34). The purpose of this grant is to support planning for the development of a full application for a translational center that will develop/apply quantitative systems pharmacology approaches to the validation of therapeutic targets and characterization of drug candidates throughout preclinical and early clinical drug development to provide a systems level understanding of drug targets and drug action and address some of . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | March 7, 2014

Federal Government Announces Planning Grants for Alzheimer’s Disease Translational Centers for Predictive Drug Development (R34) Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member